As one example, at a recent Oncologic Drugs Advisory Committee of FDA, the committee unanimously voted in favor of using minimal residual disease (MRD) negativity as an early endpoint to support accelerated approval for multiple myeloma (898)
To streamline the process, FDAs Oncology Center of Excellence (OCE) was established in 2017 under the 21st Century Cures Act and collaborates with three FDA product centers: the Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), and Center for Devices and Radiological Health (CDRH)
Enrolling in an insurance billing course for therapists can help providers enhance their knowledge
There is a concomitant need to standardize the collection, security, and dissemination of this information for patients, caregivers, clinicians, and researchers
CDC funds the North American Association of Central Cancer Registries (NAACCR) program, a core cancer surveillance system across the United States